Literature DB >> 30374827

Detection of EBV and HHV6 in the Brain Tissue of Patients with Rasmussen's Encephalitis.

Dong Liu1, Xin Wang2, Yisong Wang2, Peigang Wang2, Dongying Fan2, Sichang Chen3, Yuguang Guan1, Tianfu Li1,4, Jing An5,6, Guoming Luan7,8,9.   

Abstract

Rasmussen's encephalitis (RE) is a rare pediatric neurological disorder, and the exact etiology is not clear. Viral infection may be involved in the pathogenesis of RE, but conflicting results have reported. In this study, we evaluated the expression of both Epstein-Barr virus (EBV) and human herpes virus (HHV) 6 antigens in brain sections from 30 patients with RE and 16 control individuals by immunohistochemistry. In the RE group, EBV and HHV6 antigens were detected in 56.7% (17/30) and 50% (15/30) of individuals, respectively. In contrast, no detectable EBV and HHV6 antigen expression was found in brain tissues of the control group. The co-expression of EBV and HHV6 was detected in 20.0% (6/30) of individuals. In particular, a 4-year-old boy had a typical clinical course, including a medical history of viral encephalitis, intractable epilepsy, and hemispheric atrophy. The co-expression of EBV and HHV6 was detected in neurons and astrocytes in the brain tissue, accompanied by a high frequency of CD8+ T cells. Our results suggest that EBV and HHV6 infection and the activation of CD8+ T cells are involved in the pathogenesis of RE.

Entities:  

Keywords:  CD8+ T cells; Epstein-Barr virus (EBV); Human herpes virus 6 (HHV6); Rasmussen’s encephalitis (RE); Seizures

Mesh:

Substances:

Year:  2018        PMID: 30374827      PMCID: PMC6235760          DOI: 10.1007/s12250-018-0063-9

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  20 in total

1.  Focal seizures due to chronic localized encephalitis.

Authors:  T RASMUSSEN; J OLSZEWSKI; D LLOYDSMITH
Journal:  Neurology       Date:  1958-06       Impact factor: 9.910

2.  The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies.

Authors:  Carlos A Pardo; Eileen P G Vining; Liping Guo; Richard L Skolasky; Benjamin S Carson; John M Freeman
Journal:  Epilepsia       Date:  2004-05       Impact factor: 5.864

3.  Epstein-Barr virus in brain and Rasmussen's encephalitis.

Authors:  G F Walter; R R Renella
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

Review 4.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

5.  "Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.

Authors:  Doron Merkler; Edit Horvath; Wolfgang Bruck; Rolf M Zinkernagel; Juan Carlos Del la Torre; Daniel D Pinschewer
Journal:  J Clin Invest       Date:  2006-04-06       Impact factor: 14.808

6.  Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.

Authors:  Christian G Bien; Jan Bauer; Thomas L Deckwerth; Heinz Wiendl; Martina Deckert; Otmar D Wiestler; Johannes Schramm; Christian E Elger; Hans Lassmann
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

7.  Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.

Authors:  Christian G Bien; Henning Tiemeier; Robert Sassen; Stefan Kuczaty; Horst Urbach; Marec von Lehe; Albert J Becker; Thomas Bast; Peter Herkenrath; Michael Karenfort; Bernd Kruse; Gerhard Kurlemann; Sabine Rona; Susanne Schubert-Bast; Silvia Vieker; Stefan Vlaho; Bernd Wilken; Christian E Elger
Journal:  Epilepsia       Date:  2012-12-06       Impact factor: 5.864

8.  Cytomegalovirus and Rasmussen's encephalitis.

Authors:  C Power; S D Poland; W T Blume; J P Girvin; G P Rice
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

9.  Innate immune modulation in EBV infection.

Authors:  Shunbin Ning
Journal:  Herpesviridae       Date:  2011-01-05

10.  The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell.

Authors:  S Zaki Salahuddin; Katherine A Snyder; Andre Godwin; Renu Grewal; John G Prichard; Ann S Kelley; Dennis Revie
Journal:  Virol J       Date:  2007-10-24       Impact factor: 4.099

View more
  6 in total

1.  Association between human herpesvirus 6 (HHV-6) and cognitive function in the elderly population in Shenzhen, China.

Authors:  Chao Huang; Wei Liu; Xiaohu Ren; Yuan Lv; Lu Wang; Jia Huang; Feiqi Zhu; Desheng Wu; Li Zhou; Xinfeng Huang; Jianjun Liu
Journal:  Aging Clin Exp Res       Date:  2022-06-29       Impact factor: 3.636

2.  Human Herpesvirus-6 and -7 in the Brain Microenvironment of Persons with Neurological Pathology and Healthy People.

Authors:  Sandra Skuja; Simons Svirskis; Modra Murovska
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

3.  Differential Impacts of HHV-6A versus HHV-6B Infection in Differentiated Human Neural Stem Cells.

Authors:  Elham Bahramian; Mercede Furr; Jerry T Wu; Ruben Michael Ceballos
Journal:  Front Immunol       Date:  2022-07-13       Impact factor: 8.786

4.  Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome.

Authors:  A Orsini; G Costagliola; D Perna; M G Esposito; L Bonfiglio; P Striano; D Peroni; R Consolini; A Bonuccelli
Journal:  Epilepsy Behav Rep       Date:  2019-10-21

Review 5.  The Presence of Human Herpesvirus 6 in the Brain in Health and Disease.

Authors:  Gabriel Santpere; Marco Telford; Pol Andrés-Benito; Arcadi Navarro; Isidre Ferrer
Journal:  Biomolecules       Date:  2020-11-06

6.  Human herpesvirus 6 and epilepsy.

Authors:  William H Theodore; Emily Leibovitch; Bridgette J Billioux; Sara K Inati; Kareem Zaghloul; John Heiss; William D Gaillard; Steven Jacobson
Journal:  Epilepsia Open       Date:  2021-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.